NL-OMON42888已完成不适用
Accumulation of advanced glycation endproducts in patients with systemic amyloidosis. - AGE in Amyloïdosis
Reumatologie en Klinische Immunologie0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •ATTR amyloidosis:
- •- Written informed consent
- •- Patient has genotyped TTR mutation with diagnosis of ATTR (congo red positive tissue
- •specimen) or wild-type ATTR amyloidosis (confirmed TTR amyloid by immunohistochemistry
- •without mutation in TTR gene).;AL amyloidosis:
- •- Written informed consent
- •- Congo red positive tissue specimen and the presence of a clonal plasma cell dyscrasia. Plasma
- •cell dyscrasia is diagnosed when a free kappa or lambda light chain is detected in serum of urine
- •by immunofixation electrophoresis or when a relative excess of cells producing one of the two light
- •chains is detected in bone marrow.
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
Role of periodontits in increasing the advanced glycation end products in diabetic patientsCTRI/2021/11/038064Manipal College of Dental Sciences Manipal
进行中（未招募）
不适用
A new non-invasive method to assess cardiovascular risks in type 2 diabetic patients and the correlation to treatment typesType 2 diabetes mellitusNutritional, Metabolic, EndocrineISRCTN50136555Melk General Hospital180
已完成
不适用
Are the levels of Advanced Glycation Endproducts (AGE*s) associated with Paratonia in Alzheimer*s Disease (AD)?Paratonia/ Movement stiffness100184241002803710012272NL-OMON38761Hanzehogeschool Groningen144
已完成
不适用
evels of advanced glycation end products in the skin of patients with gingivitis and periodontitisK05Gingivitis and periodontal diseasesDRKS00031545Klinik für Innere Medizin I & SH-Exzellenz-Lehrstuhl für Innere Medizin - Endokrinologie, Diabetologie und klinische Ernährungsmedizin, UKSH,168
尚未招募
不适用
Relationship between advanced glycogen endproduct level measured by non-invasive fluorescent AGE analyzer and FGM-monitored glycemic fluctuations in type 2 diabetesJPRN-UMIN000047750Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University80